TABLE 2.
Role of EGFR | Study model | Intervention | Results | Refs. |
---|---|---|---|---|
Amphiregulin via EGFR activation increases cardiac fibrosis after myocardial infarction | C57BL6 mice | Amphiregulin and gefitinib | • Amphiregulin, via EGFR activation, promoted cardiac fibroblast migration, proliferation, and collagen synthesis (gefitinib abrogated all these effects) | Liu et al. (2020) |
• Amphiregulin deletion improved cardiac function and increased survival rate | ||||
EGFR contribute to myocardial infarction in T2D | T2D mice (db−/db−) | Group 1: Untreated | • EGFR and ER stress inhibitors reduced the cell apoptosis, inflammation, and myocardial infarct size in T2D mice after myocardial I/R injury induction | Mali et al. (2018) |
Group 2: AG1478 | ||||
Group 3: Tudca | ||||
EGFR plays a role cardiac fibrosis | C57Bl/6J mice | Generation of osteoglycin-null mice (OGN-/-) | • OGN, via EGFR inhibition, negatively regulated cardiac fibrosis by attenuating myofibroblast proliferation and migration | Zuo et al. (2018) |
Ang II infusion | • Chronic Ang II infusion in OGN deficient mice increased cardiac fibrosis and impaired cardiac function | |||
EGFR increases cardiac remodeling in diabetic cardiomyopathy | C57/BL6 mice | Gefitinib and ramipril | • Gefitinib, via EGFR inhibition, prevented lipid peroxidation, antioxidant enzymes damage, myocardial hypertrophy, myocardial damage and improved Ca2+ homeostasis in STZ-induced cardiomyopathy | Shah et al. (2018) |
EGFR induces cardiac hypertrophy | C57BL/6 mice | AG1478, 542 and 54 | • AG1478, 542 and 543, via EGFR inhibition, attenuated ang II- and EGF-induced cardiac hypertrophy | Peng et al. (2016) |
EGFR contributes to cardiac inflammation and injury associated with high fiber diet | Apo-E knockout mice | AG1478 and 542 | • EGFR inhibitors attenuated palmitic acid and hyperlipidemia-induced cardiac injury and inflammation in mice fed with high fat | (Li et al., 2016) |
EGFR role in cardiac damage and remodeling through oxidative stress | STZ-induced T1D mice | AG1478 and 451 | • AG1478 and 451, via EGFR inhibition, decreased diabetes-induced oxidative stress, cardiac remodeling, hypertrophy, fibrosis and apoptosis | Liang et al. (2015) |
EGFR and its downstream ER stress lead to cardiac injury and microvascular dysfunction in T1D | C57BL/6J | STZ only or in combination with AG1478, tudca or insulin | • AG1478, tudca, and insulin reduced cardiac fibrosis, collagen type I, and plasminogen activator inhibitor 1 and restored the impaired epithelium dependent and independent relaxation responses in T1D mice | Galan et al. (2012) |
EGFR contributes to ROS production and cardiac damage | Wistar rats | Aldosterone and EGF | • Aldosterone-induced NHE-1 stimulation, via EGFR transactivation resulted in ROS production and cardiac injury | De Giusti et al. (2011) |
T2D, type 2 diabetes; ER, endoplasmic reticulum; I/R, ischemia/reperfusion; Ang II, angiotensin II; STZ, streptozocin; ApoE, apolipoprotein E; ROS, reactive oxygen species; NHE, sodium hydrogen exporter.